In the BioHarmony Drug Report Database
Zanamivir
Relenza, Dectova (zanamivir) is a small molecule pharmaceutical. Zanamivir was first approved as Relenza on 1999-07-26. It is used to treat human influenza in the USA. It has been approved in Europe to treat human influenza.
Trade Name
|
Dectova |
|---|---|
Common Name
|
zanamivir |
ChEMBL ID
|
CHEMBL222813 |
Indication
|
human influenza |
Drug Class
|
Antivirals: neuraminidase inhibitors |
Image (chem structure or protein)